Liver Disease Therapeutics Market Size & Growth Forecast 2026–2035, By Segments (Disease, Product), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape

Chapter 1. Methodology and Scope

• Methodology segmentation & scope
• Market Definitions
• Research Methodology
• Research Scope and Assumptions

Chapter 2. Executive Summary

• Market Outlook
• Segment Outlook
• Competitive Insights

Chapter 3. Liver Disease Therapeutics Industry Insights

• Market Introduction
• Industry Value Chain Analysis
• Market Dynamics
  • Market Drivers Analysis
  • Market Restraints Analysis
  • Industry Opportunities
• Regulatory Framework
• Analysis Tools
  • Porter’s Analysis
    • Bargaining Power of the Suppliers
    • Bargaining Power of the Buyers
    • Threats of Substitution
    • Threats From New Entrants
  • PESTEL Analysis
    • Political Landscape
    • Economic and Social Landscape
    • Technological Landscape
    • Environmental Landscape
    • Legal Landscape

Chapter 4. Liver Disease Therapeutics Market Estimates 2022–2035 (USD Billion) & Trend Analysis, by Disease

• Hepatitis Segment Estimates and Forecasts, 2022–2035 (USD Billion)
• Autoimmune Diseases Segment Estimates and Forecasts, 2022–2035 (USD Billion)
• Non-alcoholic Fatty Liver Disease (NAFLD) Segment Estimates and Forecasts, 2022–2035 (USD Billion)
• Cancer Segment Estimates and Forecasts, 2022–2035 (USD Billion)
• Genetic Disorders Segment Estimates and Forecasts, 2022–2035 (USD Billion)
• Others Segment Estimates and Forecasts, 2022–2035 (USD Billion)

Chapter 5. Liver Disease Therapeutics Market Estimates 2022–2035 (USD Billion) & Trend Analysis, by Product

• Antiviral Drugs Segment Estimates and Forecasts, 2022–2035 (USD Billion)
• Vaccines Segment Estimates and Forecasts, 2022–2035 (USD Billion)
• Chemotherapy Segment Estimates and Forecasts, 2022–2035 (USD Billion)
• Targeted Therapy Segment Estimates and Forecasts, 2022–2035 (USD Billion)
• Immunosuppressants Segment Estimates and Forecasts, 2022–2035 (USD Billion)
• Immunoglobulins Segment Estimates and Forecasts, 2022–2035 (USD Billion)
• Corticosteroids Segment Estimates and Forecasts, 2022–2035 (USD Billion)
• Others Segment Estimates and Forecasts, 2022–2035 (USD Billion)

Chapter 6. Liver Disease Therapeutics Market Estimates 2022–2035 (USD Billion) & Trend Analysis, by Region & Countries

• Liver Disease Therapeutics Share, By Region
• North America
  • Market Estimates and Forecasts, 2022–2035 (USD Billion)
  • Market Estimates and Forecast by Disease, 2022–2035 (USD Billion)
  • Market Estimates and Forecast by Product, 2022–2035 (USD Billion)
  • U.S.
    • Market Estimates and Forecasts, 2022–2035 (USD Billion)
    • Market Estimates and Forecast by Disease, 2022–2035 (USD Billion)
    • Market Estimates and Forecast by Product, 2022–2035 (USD Billion)
  • Canada
    • Market Estimates and Forecasts, 2022–2035 (USD Billion)
    • Market Estimates and Forecast by Disease, 2022–2035 (USD Billion)
    • Market Estimates and Forecast by Product, 2022–2035 (USD Billion)
• Europe
  • Market Estimates and Forecasts, 2022–2035 (USD Billion)
  • Market Estimates and Forecast by Disease, 2022–2035 (USD Billion)
  • Market Estimates and Forecast by Product, 2022–2035 (USD Billion)
  • UK
    • Market Estimates and Forecasts, 2022–2035 (USD Billion)
    • Market Estimates and Forecast by Disease, 2022–2035 (USD Billion)
    • Market Estimates and Forecast by Product, 2022–2035 (USD Billion)
  • Germany
    • Market Estimates and Forecasts, 2022–2035 (USD Billion)
    • Market Estimates and Forecast by Disease, 2022–2035 (USD Billion)
    • Market Estimates and Forecast by Product, 2022–2035 (USD Billion)
  • France
    • Market Estimates and Forecasts, 2022–2035 (USD Billion)
    • Market Estimates and Forecast by Disease, 2022–2035 (USD Billion)
    • Market Estimates and Forecast by Product, 2022–2035 (USD Billion)
  • Italy
    • Market Estimates and Forecasts, 2022–2035 (USD Billion)
    • Market Estimates and Forecast by Disease, 2022–2035 (USD Billion)
    • Market Estimates and Forecast by Product, 2022–2035 (USD Billion)
  • Spain
    • Market Estimates and Forecasts, 2022–2035 (USD Billion)
    • Market Estimates and Forecast by Disease, 2022–2035 (USD Billion)
    • Market Estimates and Forecast by Product, 2022–2035 (USD Billion)
  • Russia
    • Market Estimates and Forecasts, 2022–2035 (USD Billion)
    • Market Estimates and Forecast by Disease, 2022–2035 (USD Billion)
    • Market Estimates and Forecast by Product, 2022–2035 (USD Billion)
• Asia Pacific
  • Market Estimates and Forecasts, 2022–2035 (USD Billion)
  • Market Estimates and Forecast by Disease, 2022–2035 (USD Billion)
  • Market Estimates and Forecast by Product, 2022–2035 (USD Billion)
  • China
    • Market Estimates and Forecasts, 2022–2035 (USD Billion)
    • Market Estimates and Forecast by Disease, 2022–2035 (USD Billion)
    • Market Estimates and Forecast by Product, 2022–2035 (USD Billion)
  • India
    • Market Estimates and Forecasts, 2022–2035 (USD Billion)
    • Market Estimates and Forecast by Disease, 2022–2035 (USD Billion)
    • Market Estimates and Forecast by Product, 2022–2035 (USD Billion)
  • Japan
    • Market Estimates and Forecasts, 2022–2035 (USD Billion)
    • Market Estimates and Forecast by Disease, 2022–2035 (USD Billion)
    • Market Estimates and Forecast by Product, 2022–2035 (USD Billion)
  • Australia
    • Market Estimates and Forecasts, 2022–2035 (USD Billion)
    • Market Estimates and Forecast by Disease, 2022–2035 (USD Billion)
    • Market Estimates and Forecast by Product, 2022–2035 (USD Billion)
  • South Korea
    • Market Estimates and Forecasts, 2022–2035 (USD Billion)
    • Market Estimates and Forecast by Disease, 2022–2035 (USD Billion)
    • Market Estimates and Forecast by Product, 2022–2035 (USD Billion)
• Latin America
  • Market Estimates and Forecasts, 2022–2035 (USD Billion)
  • Market Estimates and Forecast by Disease, 2022–2035 (USD Billion)
  • Market Estimates and Forecast by Product, 2022–2035 (USD Billion)
  • Mexico
    • Market Estimates and Forecasts, 2022–2035 (USD Billion)
    • Market Estimates and Forecast by Disease, 2022–2035 (USD Billion)
    • Market Estimates and Forecast by Product, 2022–2035 (USD Billion)
  • Brazil
    • Market Estimates and Forecasts, 2022–2035 (USD Billion)
    • Market Estimates and Forecast by Disease, 2022–2035 (USD Billion)
    • Market Estimates and Forecast by Product, 2022–2035 (USD Billion)
  • Argentina
    • Market Estimates and Forecasts, 2022–2035 (USD Billion)
    • Market Estimates and Forecast by Disease, 2022–2035 (USD Billion)
    • Market Estimates and Forecast by Product, 2022–2035 (USD Billion)
• Middle East & Africa
  • Market Estimates and Forecasts, 2022–2035 (USD Billion)
  • Market Estimates and Forecast by Disease, 2022–2035 (USD Billion)
  • Market Estimates and Forecast by Product, 2022–2035 (USD Billion)
  • Saudi Arabia
    • Market Estimates and Forecasts, 2022–2035 (USD Billion)
    • Market Estimates and Forecast by Disease, 2022–2035 (USD Billion)
    • Market Estimates and Forecast by Product, 2022–2035 (USD Billion)
  • UAE
    • Market Estimates and Forecasts, 2022–2035 (USD Billion)
    • Market Estimates and Forecast by Disease, 2022–2035 (USD Billion)
    • Market Estimates and Forecast by Product, 2022–2035 (USD Billion)
  • South Africa
    • Market Estimates and Forecasts, 2022–2035 (USD Billion)
    • Market Estimates and Forecast by Disease, 2022–2035 (USD Billion)
    • Market Estimates and Forecast by Product, 2022–2035 (USD Billion)

Chapter 7. Competitive Landscape

• Company Overview
• Company Market Share Analysis
• Company Heat Map Analysis
• Company SWOT Analysis
• Company Financial Performance
• Strategy Mapping
  • Expansion
  • Mergers & Acquisition
  • Partnerships & Collaborations
  • New Product Launches
  • Research and Development
• Company Profiles
  • Gilead Sciences Inc. (United States)
  • AbbVie Inc. (United States)
  • Bristol-Myers Squibb Company (United States)
  • F. Hoffmann-La Roche Ltd. (Switzerland)
  • Takeda Pharmaceutical Company Limited (Japan)
  • Johnson & Johnson (United States)
  • Merck & Co. Inc. (United States)
  • Novartis AG (Switzerland)
  • Pfizer Inc. (United States)
  • Sanofi S.A. (France)

List of Tables

• Global Liver Disease Therapeutics Market, 2022–2035 (USD Billion)
• Global Liver Disease Therapeutics Market, by Region, 2022–2035 (USD Billion)
• Global Liver Disease Therapeutics Market, by Disease, 2022–2035 (USD Billion)
• Global Liver Disease Therapeutics Market, by Product, 2022–2035 (USD Billion)
• Hepatitis Segment by Region, 2022–2035 (USD Billion)
• Autoimmune Diseases Segment by Region, 2022–2035 (USD Billion)
• Non-alcoholic Fatty Liver Disease (NAFLD) Segment by Region, 2022–2035 (USD Billion)
• Cancer Segment by Region, 2022–2035 (USD Billion)
• Genetic Disorders Segment by Region, 2022–2035 (USD Billion)
• Others Segment by Region, 2022–2035 (USD Billion)
• Antiviral Drugs Segment by Region, 2022–2035 (USD Billion)
• Vaccines Segment by Region, 2022–2035 (USD Billion)
• Chemotherapy Segment by Region, 2022–2035 (USD Billion)
• Targeted Therapy Segment by Region, 2022–2035 (USD Billion)
• Immunosuppressants Segment by Region, 2022–2035 (USD Billion)
• Immunoglobulins Segment by Region, 2022–2035 (USD Billion)
• Corticosteroids Segment by Region, 2022–2035 (USD Billion)
• Others Segment by Region, 2022–2035 (USD Billion)
• North America Liver Disease Therapeutics Market, by Disease, 2022–2035 (USD Billion)
• North America Liver Disease Therapeutics Market, by Product, 2022–2035 (USD Billion)
• U.S. Liver Disease Therapeutics Market, by Disease, 2022–2035 (USD Billion)
• U.S. Liver Disease Therapeutics Market, by Product, 2022–2035 (USD Billion)
• Canada Liver Disease Therapeutics Market, by Disease, 2022–2035 (USD Billion)
• Canada Liver Disease Therapeutics Market, by Product, 2022–2035 (USD Billion)
• Europe Liver Disease Therapeutics Market, by Disease, 2022–2035 (USD Billion)
• Europe Liver Disease Therapeutics Market, by Product, 2022–2035 (USD Billion)
• UK Liver Disease Therapeutics Market, by Disease, 2022–2035 (USD Billion)
• UK Liver Disease Therapeutics Market, by Product, 2022–2035 (USD Billion)
• Germany Liver Disease Therapeutics Market, by Disease, 2022–2035 (USD Billion)
• Germany Liver Disease Therapeutics Market, by Product, 2022–2035 (USD Billion)
• France Liver Disease Therapeutics Market, by Disease, 2022–2035 (USD Billion)
• France Liver Disease Therapeutics Market, by Product, 2022–2035 (USD Billion)
• Italy Liver Disease Therapeutics Market, by Disease, 2022–2035 (USD Billion)
• Italy Liver Disease Therapeutics Market, by Product, 2022–2035 (USD Billion)
• Spain Liver Disease Therapeutics Market, by Disease, 2022–2035 (USD Billion)
• Spain Liver Disease Therapeutics Market, by Product, 2022–2035 (USD Billion)
• Russia Liver Disease Therapeutics Market, by Disease, 2022–2035 (USD Billion)
• Russia Liver Disease Therapeutics Market, by Product, 2022–2035 (USD Billion)
• Asia Pacific Liver Disease Therapeutics Market, by Disease, 2022–2035 (USD Billion)
• Asia Pacific Liver Disease Therapeutics Market, by Product, 2022–2035 (USD Billion)
• China Liver Disease Therapeutics Market, by Disease, 2022–2035 (USD Billion)
• China Liver Disease Therapeutics Market, by Product, 2022–2035 (USD Billion)
• India Liver Disease Therapeutics Market, by Disease, 2022–2035 (USD Billion)
• India Liver Disease Therapeutics Market, by Product, 2022–2035 (USD Billion)
• Japan Liver Disease Therapeutics Market, by Disease, 2022–2035 (USD Billion)
• Japan Liver Disease Therapeutics Market, by Product, 2022–2035 (USD Billion)
• Australia Liver Disease Therapeutics Market, by Disease, 2022–2035 (USD Billion)
• Australia Liver Disease Therapeutics Market, by Product, 2022–2035 (USD Billion)
• South Korea Liver Disease Therapeutics Market, by Disease, 2022–2035 (USD Billion)
• South Korea Liver Disease Therapeutics Market, by Product, 2022–2035 (USD Billion)
• Latin America Liver Disease Therapeutics Market, by Disease, 2022–2035 (USD Billion)
• Latin America Liver Disease Therapeutics Market, by Product, 2022–2035 (USD Billion)
• Mexico Liver Disease Therapeutics Market, by Disease, 2022–2035 (USD Billion)
• Mexico Liver Disease Therapeutics Market, by Product, 2022–2035 (USD Billion)
• Brazil Liver Disease Therapeutics Market, by Disease, 2022–2035 (USD Billion)
• Brazil Liver Disease Therapeutics Market, by Product, 2022–2035 (USD Billion)
• Argentina Liver Disease Therapeutics Market, by Disease, 2022–2035 (USD Billion)
• Argentina Liver Disease Therapeutics Market, by Product, 2022–2035 (USD Billion)
• Middle East & Africa Liver Disease Therapeutics Market, by Disease, 2022–2035 (USD Billion)
• Middle East & Africa Liver Disease Therapeutics Market, by Product, 2022–2035 (USD Billion)
• UAE Liver Disease Therapeutics Market, by Disease, 2022–2035 (USD Billion)
• UAE Liver Disease Therapeutics Market, by Product, 2022–2035 (USD Billion)
• Saudi Arabia Liver Disease Therapeutics Market, by Disease, 2022–2035 (USD Billion)
• Saudi Arabia Liver Disease Therapeutics Market, by Product, 2022–2035 (USD Billion)
• South Africa Liver Disease Therapeutics Market, by Disease, 2022–2035 (USD Billion)
• South Africa Liver Disease Therapeutics Market, by Product, 2022–2035 (USD Billion)

List of Figures

• Market Snapshot
• Segment Snapshot
• Competitive Landscape Snapshot
• Industry Value Chain Analysis
• Market Dynamics
• PORTER’s Analysis
• PESTEL Analysis
• Liver Disease Therapeutics Market Estimates and Forecasts, 2022–2035 (USD Billion), by Disease
• Hepatitis Segment Estimates and Forecasts, 2022–2035 (USD Billion)
• Autoimmune Diseases Segment Estimates and Forecasts, 2022–2035 (USD Billion)
• Non-alcoholic Fatty Liver Disease (NAFLD) Segment Estimates and Forecasts, 2022–2035 (USD Billion)
• Cancer Segment Estimates and Forecasts, 2022–2035 (USD Billion)
• Genetic Disorders Segment Estimates and Forecasts, 2022–2035 (USD Billion)
• Others Segment Estimates and Forecasts, 2022–2035 (USD Billion)
• Liver Disease Therapeutics Market Estimates and Forecasts, 2022–2035 (USD Billion), by Product
• Antiviral Drugs Segment Estimates and Forecasts, 2022–2035 (USD Billion)
• Vaccines Segment Estimates and Forecasts, 2022–2035 (USD Billion)
• Chemotherapy Segment Estimates and Forecasts, 2022–2035 (USD Billion)
• Targeted Therapy Segment Estimates and Forecasts, 2022–2035 (USD Billion)
• Immunosuppressants Segment Estimates and Forecasts, 2022–2035 (USD Billion)
• Immunoglobulins Segment Estimates and Forecasts, 2022–2035 (USD Billion)
• Corticosteroids Segment Estimates and Forecasts, 2022–2035 (USD Billion)
• Others Segment Estimates and Forecasts, 2022–2035 (USD Billion)
• Global Liver Disease Therapeutics Market Share, by Region
• North America Liver Disease Therapeutics Market Estimates and Forecasts, 2022–2035 (USD Billion)
• U.S. Liver Disease Therapeutics Market Estimates and Forecasts, 2022–2035 (USD Billion)
• Canada Liver Disease Therapeutics Market Estimates and Forecasts, 2022–2035 (USD Billion)
• Europe Liver Disease Therapeutics Market Estimates and Forecasts, 2022–2035 (USD Billion)
• UK Liver Disease Therapeutics Market Estimates and Forecasts, 2022–2035 (USD Billion)
• Germany Liver Disease Therapeutics Market Estimates and Forecasts, 2022–2035 (USD Billion)
• France Liver Disease Therapeutics Market Estimates and Forecasts, 2022–2035 (USD Billion)
• Italy Liver Disease Therapeutics Market Estimates and Forecasts, 2022–2035 (USD Billion)
• Spain Liver Disease Therapeutics Market Estimates and Forecasts, 2022–2035 (USD Billion)
• Russia Liver Disease Therapeutics Market Estimates and Forecasts, 2022–2035 (USD Billion)
• Asia Pacific Liver Disease Therapeutics Market Estimates and Forecasts, 2022–2035 (USD Billion)
• China Liver Disease Therapeutics Market Estimates and Forecasts, 2022–2035 (USD Billion)
• India Liver Disease Therapeutics Market Estimates and Forecasts, 2022–2035 (USD Billion)
• Japan Liver Disease Therapeutics Market Estimates and Forecasts, 2022–2035 (USD Billion)
• Australia Liver Disease Therapeutics Market Estimates and Forecasts, 2022–2035 (USD Billion)
• South Korea Liver Disease Therapeutics Market Estimates and Forecasts, 2022–2035 (USD Billion)
• Latin America Liver Disease Therapeutics Market Estimates and Forecasts, 2022–2035 (USD Billion)
• Mexico Liver Disease Therapeutics Market Estimates and Forecasts, 2022–2035 (USD Billion)
• Brazil Liver Disease Therapeutics Market Estimates and Forecasts, 2022–2035 (USD Billion)
• Argentina Liver Disease Therapeutics Market Estimates and Forecasts, 2022–2035 (USD Billion)
• Middle East & Africa Liver Disease Therapeutics Market Estimates and Forecasts, 2022–2035 (USD Billion)
• UAE Liver Disease Therapeutics Market Estimates and Forecasts, 2022–2035 (USD Billion)
• Saudi Arabia Liver Disease Therapeutics Market Estimates and Forecasts, 2022–2035 (USD Billion)
• South Africa Liver Disease Therapeutics Market Estimates and Forecasts, 2022–2035 (USD Billion)
• Key Company Categorization
• Company Market Positioning
• Key Company Market Share Analysis